
Palmet G 1mg/500mg Tablet ER
Marketer
Palvin Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Palmet G 1mg/500mg Tablet ER
Diabeticard Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose control. Diabeticard Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical guidance risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is essential; regular meals are also vital. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or breastfeeding individuals should seek medical consultation. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to evaluate blood cell counts and liver function.
Primary Ingredients of Palmet G 1mg/500mg Tablet ER
No text provided. Please provide the text you wish to be rephrased.
Uses of Palmet G 1mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Palmet G 1mg/500mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Palmet G 1mg/500mg Extended-Release tablets should be administered with a meal.
Common Side effects of Palmet G 1mg/500mg Tablet ER:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Palmet G 1mg/500mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Palmet G 1mg/500mg Extended-Release tablets should be administered with a meal.
How Palmet G 1mg/500mg Tablet ER works:
Palmet G Extended-Release tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Palmet G 1mg/500mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Palmet G (1mg/500mg) tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Palmet G 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Exercise caution when administering Palmet G 1mg/500mg Extended-Release tablets to individuals with impaired kidney function. Dosage modification of Palmet G 1mg/500mg Extended-Release tablets may be necessary; physician consultation is recommended. In patients exhibiting severe kidney disease, the use of Palmet G 1mg/500mg Extended-Release tablets is contraindicated. Close monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Palmet G 1mg/500mg Extended-Release tablets cautiously. Dosage modification may be necessary for these patients. Physician consultation is advised. A reduced initial dose is typically recommended for individuals with mild to moderate hepatic dysfunction; however, use is contraindicated in those with severe liver disease.
What if you forget to take Palmet G 1mg/500mg Tablet ER :
Should you forget to take your Palmet G 1mg/500mg Extended-Release tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Palmet G 1mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
